Our Team
Our research team, comprised of leading experts in cardiology, electrophysiology, clinical research, and biostatistics, is dedicated to advancing the study of heart failure and implantable cardioverter defibrillators (ICDs). We emphasize a patient-centered approach, integrating valuable insights from patient partners to ensure our research addresses real-world needs.
Our Team
Dr. Ilan Goldenberg
Contact PI, Dual PI, and CCC PI – Principal Investigator of the overall trial and Clinical Coordinating Center (CCC).
Dr. Wojciech Zareba
Dual PI and DCC PI – Principal Investigator of the Data Coordinating Center (DCC).
Dr. Javed Butler
Co-PI of the CCC – Leading heart failure specialist and health economic components leader.
Dr. Robert Strawderman
Co-PI of the DCC – Responsible for database management, reporting, and leading data analyses.
Ms. Mary Brown
Lead Manager – Oversees coordination of DCC activities and supervises quality control and data acquisition management.
Dr. Samuel Sears
Lead of Quality of Life and Patient Reported Outcome Core – Oversees QoL and patient-reported outcomes.
Dr. Valentina Kutyifa
Chair of Recruitment Committee – Assists with clinical trial preparation, protocol finalization, and recruitment strategies.
Dr. David Mortara
Endowed Professor in Cardiology, Clinical Cardiovascular Research Center, University of Rochester, USA, Dual-PI; DCC PI.
Dr. Jeffrey Alexis
MD, Medical Director for the Advanced Heart Failure Program, University of Pennsylvania, NY, USA.
Dr. Eileen Hsich
MD, Medical Director for the Heart Transplant Program Cleveland Clinic.
Dr. Alanna Morris
MD, Director of Heart Failure Services, Emory’s Center for Heart Failure Therapy and Transplantation, USA.
Dr. Ileana Pina
MD, MPH, Wayne State University and Central Michigan University, USA. Senior fellow to the Food and Drug Administrations’ Center for Devices and Radiological Health.
Dr. Christine Albert
MD, MPH, Professor of Medicine (Cardiology), Former Heart Rhythm Society President.
Katherine Honsinger
MS, CCRA.
Dr. Chad Teeters
MD, MBA is President and CEO of Noyes Health and the Executive Medical Director at Accountable Health Partners (AHP); a stakeholder with expertise in policy development and quality care improvements.
Dr. John P. Gassler
M.D. Medical Principle, Cardiovascular Subject Matter Expert, for the Affordability and Specialty Partnerships Cigna HealthCare, an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut. He will serve as a third-party payor stakeholder and will advise the Steering Committee.
Dr. Fil Guipoco
MA. Is the Director of Health Equity for the American Heart Association, with experience in implementation of public access for automatic external defibrillators.
Dr. Elijah Behr
MBBS, MD, FRCP, FESC, Professor in Cardiovascular Medicine and an honorary consultant cardiologist specialising in electrophysiology.
Dr. Lisa Anderson
MD, Heart Failure Consultant, and Honorary Reader in the Cardiovascular Clinical Academic Group, Molecular and Clinical Sciences Research Institute at St George’s Hospital in London, UK.
Dr. Roopinder K. Sandhu
Kris J. Cutter
MS, Clinical Cardiovascular Research Center, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, Rochester, New York.
Dr. Anuradha Lala-Trindade
MD, the Director of Heart Failure Research and Data Coordinating Center leadership for the NHLBI Cardiothoracic Surgery Network.
Ann Colasurdo
Senior Project Manager